Occurrence of Selected Generic Drugs 2

Project Title Occurrence of Selected Generic Drugs 2
Date Posted
Thursday, August 2, 2012
Project ID
MSY3_STR6-8
Status
Complete
Deliverables
Description

Summary table assessment of the use of 26 drug products in the Mini-Sentinel Distributed Database (Warfarin, Ambrisentan, Bosentan, Dronedarone, Lisinopril, Lisinopril/Hydrochlorothiazide, Acitretin, Acitretin/Emollient Comb. 26, Isotretinoin, Methimazole, Methotrexate, Methotrexate Sodium, Clarithromycin, Fluconazole, Telavancin, Busulfan, Chlorambucil, Cyclophosphamide, Lenalidomide, Thalidomide, Trastuzumab, Topiramate, Valproic Acid, Lithium Carbonate, Lithium Citrate, and Finasteride). Note that the following generic names include NDC codes with both oral and injection/intravenous pathways: warfarin, methotrexate, busulfan, and cyclophoshamide. The generic name Telavancin was queried, but no results were generated for this drug product. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in November 2011. This report includes information from 13 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
acitretin
acitretin/emollient combo. 26
ambrisentan
bosentan
busulfan
chlorambucil
clarithromycin
cyclophosphamide
dronedarone
finasteride
fluconazole
isotretinoin
lenalidomide
lisinopril
lisinopril/hydrochlorothiazide
lithium carbonate
lithium citrate
methimazole
methotrexate
methotrexate sodium
telavancin
thalidomide
topiramate
trastuzumab
valproic acid
warfarin
Time Period
2004 - 2010
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER